Price$0.96-0.07 (-6.80%)
01:30 PM07:45 PM
News · 26 weeks41-44%
2026-04-192026-10-11
Mix2090d
- SEC Filings10(50%)
- Insider5(25%)
- Other3(15%)
- Earnings2(10%)
Latest news
25 items- SECSEC Form 8-K filed by Upexi Inc.8-K - UPEXI, INC. (0001775194) (Filer)
- SECSEC Form DEF 14A filed by Upexi Inc.DEF 14A - UPEXI, INC. (0001775194) (Filer)
- SECSEC Form 8-K filed by Upexi Inc.8-K - UPEXI, INC. (0001775194) (Filer)
- PRUpexi to Participate in Upcoming October Investor ConferencesTAMPA, Fla., Oct. 06, 2026 (GLOBE NEWSWIRE) -- Upexi, Inc. (NASDAQ:UPXI) ("Upexi" or the "Company"), a leading Solana-focused digital asset treasury company and consumer brands owner, today announced that Brian Rudick, Chief Strategy Officer, will participate in the following October 2026 investor conferences: Maxim Growth Summit 2026 Date: October 12 – 14, 2026Location: Hard Rock Hotel, New York, NYType: Investor Meetings Webull Emerging & Innovative Companies WebinarDate and Time: Wednesday, October 14, 2026, 1:00 PM ETType: Virtual PresentationWebcast: https://ir.upexi.com/news-events/ir-calendar LD Micro 20th Annual Main Event Date: October 19 – 21, 2026Location: Luxe Sunset Blvd Ho
- SECSEC Form PRE 14A filed by Upexi Inc.PRE 14A - UPEXI, INC. (0001775194) (Filer)
- SECUpexi Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - UPEXI, INC. (0001775194) (Filer)
- SECSEC Form 10-K filed by Upexi Inc.10-K - UPEXI, INC. (0001775194) (Filer)
- PRUpexi Reports Financial Results for Fiscal Year Ended June 30, 2026Digital Asset Revenue Totaled $17.4 Million for Fiscal Year 2026 Solana Treasury Totaled Approximately 2.34 Million SOL as of June 30, 2026 Conference Call Scheduled for Today, September 17, 2026, at 5:30 P.M. E.T. TAMPA, Fla., Sept. 17, 2026 (GLOBE NEWSWIRE) -- Upexi, Inc. (NASDAQ:UPXI) (the "Company" or "Upexi"), a leading Solana-focused digital asset treasury company and consumer brands owner, today announced its financial results for the fiscal year ended June 30, 2026. "Fiscal 2026 marked the first full year of our Solana treasury strategy, and in a subdued market for digital assets we focused on what we could control," said Allan Marshall, Chief Executive Officer of Upexi. "We fo
- SECUpexi Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits8-K - UPEXI, INC. (0001775194) (Filer)
- PRUpexi to Host Fiscal Year 2026 Earnings Call on Thursday, September 17th at 5:30 P.M. ETTAMPA, Fla., Sept. 15, 2026 (GLOBE NEWSWIRE) -- Upexi, Inc. (NASDAQ:UPXI) (the "Company" or "Upexi"), a leading Solana-focused digital asset treasury company and consumer brands owner, today announced that it plans to host a conference call and report its financial results for the fiscal year 2026 ended June 30, 2026, on Thursday, September 17, 2026. Additional details are available under the Investor Relations section of the Company’s website: https://ir.upexi.com/ Event:Upexi Fiscal Year 2026 Earnings CallDate:Thursday, September 17, 2026Time:5:30 p.m. ETLive Call:1-877-407-9716 (U.S. Toll-Free) or 1-201-493-6779 (International)Webcast:https://ir.upexi.com/news-events/ir-calendar For i
- SECUpexi Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits8-K - UPEXI, INC. (0001775194) (Filer)
- PRUpexi Amends BitGo Credit FacilityTAMPA, Fla., Sept. 14, 2026 (GLOBE NEWSWIRE) -- Upexi, Inc. (NASDAQ:UPXI) ("Upexi" or the "Company"), a leading Solana-focused digital asset treasury company and consumer brands owner, today announced that it has amended its existing credit facility with BitGo Prime, LLC ("BitGo"), first entered into on May 23, 2025 under a Master Loan Agreement. Under the amended terms, the interest rate applicable to the Company’s outstanding borrowings has been reduced from 11.5% to 7.5% per year, and the required collateral level has been reduced to 200%, with a margin call level of 150%. "Under the amended credit facility, the Company, based on current borrowings outstanding, expects to save over $2
- SECUpexi Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits8-K - UPEXI, INC. (0001775194) (Filer)
- PRUpexi to Participate in FT Partners FinTech Conference 2026 on September 15thTAMPA, Fla., Sept. 08, 2026 (GLOBE NEWSWIRE) -- Upexi, Inc. (NASDAQ:UPXI) ("Upexi" or the "Company"), a leading Solana-focused digital asset treasury company and consumer brands owner, today announced that Brian Rudick, Chief Strategy Officer, will attend the FT Partners FinTech Conference 2026 being held at Convene, 601 Lexington Avenue, in New York, NY, on September 15, 2026. FT Partners FinTech Conference 2026 Details:Date: Tuesday, September 15, 2026Location: Convene, 601 Lexington Avenue, New York, NY 10022Attendees: Brian Rudick, Chief Strategy OfficerType: Investor Meetings To schedule a one-on-one meeting with Upexi’s management, please email KCSA Strategic Communications at Upex
- SECUpexi Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and Exhibits8-K - UPEXI, INC. (0001775194) (Filer)
- INSIDERDirector Salkind Gene was granted 100,000 shares, increasing direct ownership by 46% to 318,750 units (SEC Form 4)4 - UPEXI, INC. (0001775194) (Issuer)
- INSIDERDirector Dugan Lawrence was granted 100,000 shares, increasing direct ownership by 86% to 216,389 units (SEC Form 4)4 - UPEXI, INC. (0001775194) (Issuer)
- INSIDERChief Strategy Officer Rudick Brian Benjamin was granted 400,000 shares, increasing direct ownership by 48% to 1,238,597 units (SEC Form 4)4 - UPEXI, INC. (0001775194) (Issuer)
- INSIDERChief Executive Officer Marshall Allan was granted 2,000,000 shares, increasing direct ownership by 49% to 6,046,261 units (SEC Form 4)4 - UPEXI, INC. (0001775194) (Issuer)
- INSIDERChief Financial Officer Norstrud Andrew James was granted 400,000 shares, increasing direct ownership by 62% to 1,049,138 units (SEC Form 4)4 - UPEXI, INC. (0001775194) (Issuer)
- SECSEC Form EFFECT filed by Upexi Inc.EFFECT - UPEXI, INC. (0001775194) (Filer)
- SECSEC Form 424B3 filed by Upexi Inc.424B3 - UPEXI, INC. (0001775194) (Filer)
- SECSEC Form S-3 filed by Upexi Inc.S-3 - UPEXI, INC. (0001775194) (Filer)
- SECUpexi Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits8-K - UPEXI, INC. (0001775194) (Filer)
- PRUpexi Partners with Blueprint to Stake Solana Treasury AssetsTAMPA, Fla., June 30, 2026 (GLOBE NEWSWIRE) -- Upexi, Inc. (NASDAQ:UPXI) ("Upexi" or the "Company"), a leading Solana-focused digital asset treasury company and consumer brands owner, today announced a strategic partnership with Blueprint, the institutional staking and digital-asset infrastructure affiliate of Hivemind Capital Partners, to stake a portion of its Solana holdings. Through this partnership, Upexi will stake SOL with Blueprint’s institutional-grade Solana validator, leveraging the platform’s high-performance infrastructure, security standards, and track record of industry-leading validator performance. "Staking with Blueprint strengthens our long-term strategy to responsib
UPXI FAQ
6 questionsWhere does UPXI stock trade?
Upexi Inc. (UPXI) is listed on NASDAQ.What sector and industry is UPXI in?
Upexi Inc. operates in the Health Care sector, Medicinal Chemicals and Botanical Products industry.When did Upexi Inc. go public?
Upexi Inc. (UPXI) completed its IPO in 2021.What are analysts saying about UPXI?
Upexi Inc. has had 2 recent analyst actions on file. The most recent action was from Alliance Global Partners: Buy with a $1500.00 price target on 2025-08-04. Recent price targets range from $1500.00 to $1600.00.What companies are similar to UPXI?
Notable peers in the same industry include PM (Philip Morris International Inc), BTI (British American Tobacco Industries p.l.c.), MO (Altria Group Inc.), RGC (Regencell Bioscience Holdings Limited), DFTX (Definium Therapeutics Inc.). Compare UPXI side-by-side with any of them on Quantisnow.How can I track UPXI on Quantisnow?
Quantisnow aggregates Upexi Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow UPXI to receive live email and push alerts on every new disclosure.